Ventricular enlargement in MS
Authors:
- 14 March 2006
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 66 (5) , 693-698
Abstract
Objectives: To investigate ventricular enlargement (VE) over 1 year at three different stages of multiple sclerosis (MS). Methods: A semi-automated technique for measuring VE was applied to MRI scans in 26 patients with clinically isolated syndromes (CIS) suggestive of MS, 30 with early relapse-onset MS of 1 year duration, 41 with established relapsing remitting (RR) MS, and 23 with secondary progressive (SP) MS. Results: VE at 1 year was seen in early MS (median increase 0.3 mL [p = 0.003]), RRMS (median increase 0.5 mL [p = 0.001]), and SPMS (median increase 1.1 mL [p = 0.001]). Allowing for age there was more VE in the SPMS group (p = 0.005). No VE was observed in the CIS only group (median decrease −0.001 mL [p = 0.829]). Significant increases in T2 and T1 hypointense lesion load volume were seen in all MS subgroups: there were no differences between the groups in T2 volume increase but there was a larger increase in T1 hypointense lesion volume in the SPMS group compared with early RRMS. Conclusions: Ventricular enlargement is a sensitive measure of progressive cerebral atrophy that is seen at all stages of multiple sclerosis (MS) and is more marked in secondary progressive than relapsing remitting MS.Keywords
This publication has 36 references indexed in Scilit:
- Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosisNeuroImage, 2004
- Focal thinning of the cerebral cortex in multiple sclerosisBrain, 2003
- Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Brain atrophy in clinically early relapsing–remitting multiple sclerosisBrain, 2002
- Brain and Spinal Cord Atrophy in Multiple SclerosisCNS Drugs, 2001
- Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-1aMultiple Sclerosis Journal, 2000
- The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosisBrain, 2000
- Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosisAnnals of Neurology, 2000
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983